š”š²šš š¦ššŗšŗš®šæš
ā¢ Sharekhan has recommended a buy rating on Zydus Lifesciences with a target price of Rs. 687.
ā¢ In Q2FY24, the company saw a mixed bag of results with an 8% y-o-y increase in revenue but a 15% q-o-q decline due to lower US sales.
ā¢ Despite this, the company maintained its guidance of double-digit growth in the US and in-line performance in India for FY24E.